Cellectar Biosciences (CLRB) PT Raised to $12 at Oppenheimer
Tweet Send to a Friend
(Updated - March 28, 2024 7:33 AM EDT)
Oppenheimer analyst Jeff Jones raised the price target on Cellectar Biosciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jeff Jones raised the price target on Cellectar Biosciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
